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Solar Ultraviolet B Radiation Compared with
Prostate Cancer Incidence and Mortality
Rates in United States
Janet L. Colli, and William B. Grant
OBJECTIVE

METHODS

RESULTS

CONCLUSIONS

To investigate whether the prostate cancer incidence and mortality rates in the United States
correlate inversely with solar ultraviolet (UV) B radiation levels computed from a mathematical
model using forecasted ozone levels, cloud levels, and elevation. Another objective was to
explore whether the annual prostate cancer rates correlated more strongly with the cumulative
UVB exposure for the year or for exposure during certain seasons.
The age-adjusted incidence and mortality cancer rates for black and white men in the continental United States were correlated with the mean UV index values averaged for the year and
for each season.
We found an inverse correlation between the UVB levels and prostate cancer incidence (R ⫽ ⫺0.42,
P ⬍0.01) and mortality rates (R ⫽ ⫺0.53, P ⬍0.001) for white men and for incidence (R ⫽ ⫺0.40,
P ⬍0.05) for black men, but the strength of the correlation depended on the season of UVB
irradiance. No statistically significant results for black male mortality were found. The annual prostate
cancer incidence and mortality rates for white men correlated most strongly with UVB exposure
levels in the fall and winter, and incidence rates for black men correlated with UVB exposure levels
in the summer.
Increased solar UVB radiation might reduce the risk of prostate cancer, but the efficacy depends
on the season of UVB irradiance. UROLOGY 71: 531–535, 2008. © 2008 Elsevier Inc.

I

nadequate solar ultraviolet (UV) B irradiance has
been implicated as a risk factor for prostate cancer
incidence and mortality.1–7 A number of recent studies have found that the survival of patients with breast,
colon, and prostate cancer depends on the season of
diagnosis, and sunlight exposure has been suggested as
the cause.8 –10
An association between the circulating serum 25 hydroxyvitamin D [25(OH)D] (calcidiol) and a reduced risk
of prostate cancer has been suggested.11 Vitamin D is
obtained by humans from exposure to sunlight or ingestion of vitamin D.12 The hormonal form of vitamin D,
1,25-dihydroxyvitamin D3 (calcitriol) has been identified
as a potent antiproliferative and pro-differentiation hormone.13 A recent report on the epidemiology of vitamin
D and cancer incidence and mortality has provided a
thorough review of the published data on this subject.14
Most humans depend on sunlight exposure to satisfy
their requirements for vitamin D. Solar UVB radiation is
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absorbed by 7-dehydrocholesterol in the skin, leading to
its transformation to previtamin D3, which is rapidly
converted to vitamin D3. The production of vitamin D3
in the skin is affected by the season, latitude, time of day,
and skin pigmentation.15
The plan of this study was to determine whether the
prostate cancer risks in the United States correlate inversely with UV index values that were developed by the
National Oceanic and Atmospheric Administration
(NOAA) in collaboration with the Environmental Protection Agency (EPA).16 The UV index is a forecast of
the amount of UV radiation expected to reach the earth’s
surface, weighted by the McKinlay-Diffey erythema action spectrum to reflect the human skin’s response. The
UV index value is not only a more precise forecast of
UVB exposure associated with the production of vitamin
D3 than that used in past studies, but its application
allows for a probe of the relationship between annual
cancer rates and UVB radiation exposure levels for the
year and for different periods during the year.
Because UV radiation levels vary significantly throughout the year, we compared the cancer rates to the UV index
values averaged for the entire year, as well as those for each
season. The objective was to explore whether the strength
of any correlations found depended on the total annual
UVB exposure or the season in which the exposure oc-
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Table 1. Summary statistics for cancer incidence and mortality rates for states in United States
Percentile
Prostate Cancer
Incidence
White men
Black men
Mortality
White men
Black men

States (n)

Mean

Minimum

Maximum

25th

75th

43*
35†

143.6
211.1

116.1
115.5

186.0
276.1

131.9
193.0

153.2
231.0

48
33‡

32.8
73.6

27.7
53.0

39.0
87.3

31.6
69.0

33.7
78.7

Cancer incidence rates for 2003 to 2004 and mortality rates for deaths from 1992 to 2001.
* Arizona, Mississippi, Tennessee, Virginia, and Wyoming (group 1) not included.
†
Group 1 plus Idaho, Maine, Montana, New Hampshire, North Dakota, South Dakota, Utah, and Vermont not included.
‡
Idaho, Iowa, Maine, Minnesota, Montana, Nebraska, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, South Dakota,
Utah, Vermont, and Wyoming not included.

Table 2. UV index* values averaged for year and seasons for 48 states across United States
Percentile
Season

Mean

Minimum

Maximum

25th

75th

Annual
Winter
Spring
Summer
Fall

4.3
1.6
4.9
7.3
3.4

2.7
0.6
3.2
5.1
1.9

6.4
3.8
7.7
9.6
5.5

3.5
1.0
4.0
6.4
2.6

5.1
2.1
5.8
8.5
4.2

UV, ultraviolet.
UV index values are averaged from 1995 to 2001.
* UV index is erythema dose calculated from forecasted amount of ultraviolet radiation expected to reach the Earth’s surface at time when
the Sun is highest in the sky.

curred. The results could reveal whether cancer rates correlate more strongly with UVB levels in the winter when
reduced vitamin D3 synthesis occurs or UVB levels in the
summer when high levels of vitamin D3 synthesis result in
accumulation of vitamin D in body fat that becomes available for release into the circulating blood at a later time. In
winter, most humans are unable to synthesize vitamin D
from solar UVB radiation in many areas of most of the
United States.17 Because the pigmentation in the skin of
blacks inhibits the formation of vitamin D3 from UVB
radiation,18 the cancer rates for blacks and whites were
compared with UV indexes separately.

MATERIAL AND METHODS
Data Sources
The prostate cancer incidence rates for the states in the continental United States for 2000 to 2001 were obtained from the
State Cancer Registry and the National Program of Cancer
Registries Cancer Surveillance.19 The summary statistics are
presented in Table 1. The incidence data for some states were
not included in the database because the data quality standards
were not met and the data had not been published. The
incidence rates were age adjusted to the 2000 U.S. standard
population.
The cancer mortality rates for states in the continental
United States were obtained from the Surveillance, Epidemiology, and End Results program of the National Cancer Institute.20 The cancer mortality rates covered the deaths (all ages)
from 1992 to 2001 and were age adjusted to a standard population (2000 U.S. population). The states with 15 or fewer
deaths during the period studied were not included.
532

The UV index values were obtained from the NOAA, which
developed these data in collaboration with the EPA.16 The
NOAA/EPA UV index is computed from a mathematical
model using the forecasted ozone levels, cloud levels, and elevation. The model is used to determine the UV irradiance from
290 to 400 nm. The irradiance is weighted by the McKinlayDiffey erythema action spectrum, resulting in a peak value near
308 nm, with a strong weighting for the UVB range (approximately 290 to 320 nm).13 During solar UV irradiance, photons
in the UVB range are absorbed by the cutaneous 7-dehydrocholesterol to form previtamin D3.21
The NOAA/EPA UV index values for 48 states were obtained from 1995 to 2001 and averaged to dampen any variations that might have occurred from data for a single year. The
UV index values averaged for the year and for each season are
presented in Table 2. Examination of the raw data not shown
suggested that UV levels across the country are asymmetric
because of differences in surface elevation and stratospheric
ozone levels. The Rocky Mountain states have greater UV
levels (especially in the summer) than states in the Midwest or
east. The peak UV index value exceeded 9 for Utah, Colorado,
and Nevada in the summer but was approximately 7 for Illinois,
Ohio, and Virginia, which are at about the same latitude. The
differences in the UV indexes between the east and west were
less pronounced along the 30° and 40° latitude, although the
tendency was similar.

Statistical Analysis
Initially, the data for the cancer incidence and mortality rates
and UV indexes were examined for normalcy and to identify
outliers. All variables appeared to possess a normal, or near
normal, distribution, and no outliers were found in the data set.
UROLOGY 71 (3), 2008

Table 3. Correlation coefficients between prostate cancer
rates and mean UV indexes* for states in United States

UV Index
Annual
Winter
Spring
Summer
Fall

PCa Incidence
Whites
Blacks
⫺0.36†
⫺0.42§
⫺0.383
⫺0.23‡
⫺0.40§

⫺0.30‡
⫺0.20‡
⫺0.27‡
⫺0.403
⫺0.26‡

PCa Mortality
Whites
Blacks
⫺0.46§
⫺0.53¶
⫺0.48§
⫺0.31§
⫺0.50¶

0.15‡
0.24‡
0.18‡
0.03‡
0.18‡

UV, ultraviolet; PCa, prostate cancer.
Annual and seasonal mean UV indexes averaged from 1995 to
2001; cancer incidence rates for 2003 or 2004; mortality rates
for deaths from 1992 to 2001.
* UV index is erythema dose calculated from forecasted amount
of UV radiation expected to reach earth’s surface when sun is
highest in sky.
†
P ⬍0.05, two-tailed.
‡
P ⬎0.05, two-tailed.
§
P ⬍0.010, two-tailed.
¶
P ⬍0.001, two-tailed.

Outliers were defined as values outside two standard deviations
from the mean.
The cancer rates for the states were correlated with the UV
index values for the year and for each season. Simple regression
coefficients (B), correlation coefficients (R) and P values (two
sided) were calculated to examine the association between
cancer rates and monthly UV indexes in those cases with the
strongest correlation. The statistical analyses in this study were
performed using the software program Statistical Package for
Social Sciences for Windows, version 12.0 (SPSS, Chicago, Ill).

RESULTS
The correlation coefficients between the mean UV
index values and prostate cancer rates are presented in
Table 3. The maximal correlation coefficient for incidence was R ⫽ ⫺0.42 (P ⬍0.01) for white men and
R ⫽ ⫺0.40 (P ⬍0.05) for black men. The maximal
correlation coefficient for mortality for white men was
R ⫽ ⫺0.53 (P ⬍0.001). No statistically significant
results for black male mortality were found.
The prostate cancer incidence and mortality rates for
white men correlated most strongly with the UV indexes
in the fall and winter/spring, and the prostate cancer
incidence for black men correlated most strongly with
the UV index in the summer. Not only was the correlation coefficient greater in the peak season, but the P
value was smaller, suggesting a lower probability that the
results were false.
Simple regression coefficients were calculated to examine the association between cancer rates and monthly
UV indexes in cases in which the correlation was close.
The regression coefficient for the season with the strongest correlation was B ⫽ ⫺9.9 (95% confidence interval
⫺16.7 to ⫺3.2) for the incidence for white men (winter),
B ⫽ ⫺12.1 (95% confidence interval ⫺22.0 to ⫺2.2) for
the incidence for black men (summer), and B ⫽ ⫺1.6
(95% confidence interval ⫺2.4 to ⫺0.9) for mortality for
white men (winter). Outliers in the model outputs included the incidence for white men in Kentucky (116.1
UROLOGY 71 (3), 2008

actual, 144.0 calculated), the incidence for black men in
West Virginia (158.5 actual, 213.9 calculated), and mortality for white men in Wyoming (39.0 actual, 32.8
calculated). The regression coefficient for the mortality
rates for black men was 0.2 (95% confidence interval
⫺2.4 to 2.8; P ⫽ 0.88).

COMMENT
The correlation between prostate cancer rates and UV
indexes for white men was strongest in the fall and
winter, moderate in the spring, and weak or nonexistent
in the summer. These findings suggest that vitamin D
synthesis from sunlight in the spring and summer might
be sufficient to afford protection from prostate cancer for
white men in most of the United States, but that the risk
is increased from the modest amounts synthesized
throughout the rest of the year.
However, prostate cancer mortality rates have a different geographic distribution in the United States than
many of the other vitamin D-sensitive cancers. The rates
are high in the northwest and northeast, in contrast to
other cancers in which the rates are intermediate in the
northwest. Prostate cancer was the only vitamin D-sensitive cancer that had a significant correlation with latitude but not to the index of July 1992 UVB doses used in
the study by Grant and Garland.22 Latitude can be interpreted as an index of wintertime UVB related to the solar
zenith angle rather than the very pronounced asymmetry in
the summertime UVB in the United States that results from
differences in surface elevation and stratospheric ozone between the eastern and western states. A more recent study
found that several other cancers, including bladder, ovarian,
prostate, testicular, and Hodgkin’s and non-Hodgkin’s lymphoma, also had a correlation with latitude on multiple
linear regression analysis that included the summertime
UVB. Viral infections have been reported as risk factors for
these cancers. A paper23 has been submitted suggesting that
the correlation with wintertime solar UVB results from the
effect of vitamin D reducing the risk of viral respiratory
diseases in the summer.24
In contrast to the prostate cancer results for white
men, the prostate cancer incidence for black men exhibited a statistically significant correlation with the UVB
radiation levels only in the summer. Vitamin D synthesis,
which is low in the winter for whites in most of the
United States,17 is undoubtedly lower for blacks. Black
men, with increased skin melanin pigmentation, might
not be able to synthesize sufficient vitamin D from ambient UVB radiation exposure in seasons other than
summer to affect prostate cancer progression. An increase
in skin melanin pigmentation will absorb solar ultraviolet
radiation and significantly reduce the production of vitamin D3 in the skin.25 Studies of black men and Mexican Americans have suggested that they have lower
circulating concentrations of calcidiol.26 The circulating
concentration of calcidiol is reported to reflect the cu533

mulative effects of exposure to sunlight and dietary intake of vitamin D.12
Although the UV indexes correlated with the incidence of prostate cancer for black men, no correlation
was found with mortality for black men. These results are
consistent with those of another recent study.27 It is
possible that black men cannot synthesize sufficient vitamin D from ambient UVB radiation exposure to affect
disease progression after its initiation. Some studies,28 –30
although not all,31 have suggested that black men have a
more advanced form of prostate cancer at diagnosis,
which might reduce the benefits of the lower levels of
vitamin D that blacks are able to synthesize from exposure to sunlight. This would support our finding that
UVB exposure benefits the incidence but not mortality
for black men. The results in the study by Grant27 were
determined from mortality data for 1970 to 1994 in
contrast to the data in the present study which were
determined from mortality data for 1992 to 2001. Concern has been increasing about the risk of skin cancer
from solar UV irradiance starting in the early 1980s, and
indications exist that this has led to changes in the
geographic variation of cancer mortality rates in the
United States. Although black Americans are at a much
lower risk of skin cancer than are white Americans, the
skin cancer prevention messages generally do not make
that clear; thus, black Americans could be avoiding solar
UVB irradiance as well.
Our results seem to suggest that a critical sunlight
threshold exists below which the risk of prostate cancer
increases. This critical threshold is lower for white men
than for black men. For white men, this threshold is
exceeded in the whole country in the summer but is not
met in the northern part of the country in the other
seasons. This critical threshold value for white men is
approximately 5.1—the minimal UV index value for the
summer from Table 2. For black men, this threshold is
only exceeded in the summer in the south. This threshold value is about 8.1—the mean UV index value for the
states of the Southeast in the summer. Hence, the seasons
other than summer are most relevant for white men, and
the summer is the most relevant for black men.
The uncertainties in this study stemmed from a number of factors. The number of data points (especially for
cancer incidence) used in this study were not large. The
UV data were taken at one, or several, points within a
state, and variations throughout the state were not taken
into consideration. Also, the UV data were aggregated,
and what might apply on a population basis might not
necessarily be observed on an individual basis. This study
assessed total mortality as opposed to case fatality. Also,
aggregating the data by state did not allow for consideration of relationships within a state and limited the
control of confounders and effects modifiers. This study
had a number of potential biases, and the use of the UV
index as a surrogate for UV exposure has a high degree of
uncertainty. For example, varying lifestyles across the
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United States could result in differences in exposure to
solar UVB (eg, people in the west might tend to spend
more time outdoors than people in the northeast); the
amount of time that people spend outdoors varies depending on their lifestyle or occupation; difference in
clothing styles will affect the amount of UVB radiation
reaching the skin; and pigmentation varies among whites
with different skin types.

CONCLUSIONS
Increased solar UVB irradiance might reduce the risk of
prostate cancer but the efficacy could depend on the
season of UVB irradiance. Both the incidence and mortality of prostate cancer for white men correlated most
strongly with the UVB levels in the fall, winter, and
spring. The prostate cancer incidence for black men
correlated most strongly with the UVB levels in the
summer.
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